1.96BUSD
See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US00847X1046
CUSIP
00847X104
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
2.88
PEG Ratio
-
Book Value
28.53
Dividend Share
-
Dividend Yield
-
Earnings Share
11.66
Wall Street Target Price
57.00
EPS Estimate Current Year
11.21
EPS Estimate Next Year
-5.80
EPS Estimate Current Quarter
1.11
EPS Estimate Next Quarter
-1.73
Most Recent Quarter
-
Revenue TTM
32,871,000
Gross Profit TTM
-266,584,992
EBITDA
-401,288,000
Profit Margin
2051.38%
Return On Assets TTM
-18.18%
Return On Equity TTM
53.66%
Revenue Per Share TTM
0.582
Qtly Revenue Growth YOY
21.20%
Diluted Eps TTM
11.66
Qtly Earnings Growth YOY
0.00%
Trailing PE
2.88
Forward PE
2
Price Sales TTM
58.321
Price Book MRQ
1.2057
Enterprise Value Revenue
30
Enterprise Value EBITDA
-2
697.10
4.66%484.79
3.07%95.67
0.12%697.42
0.00%161.37
0.00%116.01
-3.24%190.00
-2.69%270.91
-1.34%650.81
-1.01%85.51
-0.18%